About: Dent Neurologic Institute

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dent Neurologic Institute Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

organization in Amherst, United States

Attributes	Values
rdf:type	Item
description	organisatie uit Verenigde Staten van Amerika (nl) US-amerikanische Organisation (de) американська організація (uk) منظمة في أمهرست، الولايات المتحدة (ar) organization in Amherst, United States (en)
rdfs:label	Dent Neurologic Institute (en)
skos:prefLabel	Dent Neurologic Institute (en)
name	Dent Neurologic Institute (en)
ROR ID	wds:Q30281497-F265E47D-DA31-4C99-9BAD-FFF9E6B6E6FD
ROR ID	0106aa564
instance of	wds:Q30281497-54E2B852-2768-42DF-91E7-EBAC3F7B7D78
instance of	organization
country	wds:Q30281497-280030AE-D9BC-4E6E-B4B2-46BFD7E5FEBB
country	United States of America
Ringgold ID	wds:Q30281497-CA0AF024-1D53-4399-B23C-C081610329BB
Ringgold ID	171342
inception	wds:Q30281497-DE528DE9-A979-432E-96FD-8305C493F6E1
inception	1962-01-01 00:00:00Z (xsd:dateTime)
located in the adm...erritorial entity	wds:Q30281497-52739251-22EC-4468-A676-FE11A8153174
X username	wds:Q30281497-99D83D0F-B155-4DDA-AFEE-652EB0C3BCF6
ISNI	wds:Q30281497-AB458CC1-C63E-451E-84A6-DC4A74642E1F
coordinate location	wds:Q30281497-3D9667AB-C856-4D36-8417-8E08E8164554
official website	wds:Q30281497-308A3F37-9EC5-4BFB-A1F1-63559118D9C8
located in the adm...erritorial entity	Amherst
X username	dentinstitute
ISNI	0000000404309339
coordinate location	POINT(-78.786715 42.979423)
official website	http://www.dentinstitute.com/
GRID ID	wds:Q30281497-539103C3-CAC7-4671-B04C-9C311119112F
GRID ID	grid.417854.b
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30281497
is research site of	Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine Treatment-Resistant Depression Registry Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM) Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type Valproate in Dementia (VALID) Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant Efficacy of Sumatriptan With Naprosyn in Migraine With Aura Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura Study of Lamotrigine to Treat Ménière's Disease Alzheimer's Disease Neuroimaging Initiative 2 Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema DFN-02 Open Label Safety Study in Patients With Acute Migraine To Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants
is research site of	wds:Q62111080-B2C609BA-B6CF-43CA-830D-08697806DC76 wds:Q66028126-0CD9D632-EE76-42CE-87C4-CEC7691B6A4E wds:Q61957021-ABF9F165-F344-4947-A520-C7DA6F9E8714 wds:Q62030770-439F2D7B-F4B3-4CEE-AE76-A38B9F6D02B8 wds:Q65390324-D15D59C3-4BB0-42EA-BECA-E5009449F49F wds:Q65396341-B2AFE047-0D2C-4451-AD10-6B67168D03FF wds:Q63844444-00A929D8-AEDC-492A-82AA-0B39482CC0CE wds:Q66068029-E1038F79-08E6-4990-B741-6F8229FD6A61 wds:Q64396497-F72C4143-7B83-414E-A697-46F2B2464624 wds:Q66034310-8A0C8F26-872E-4253-B8EA-F247BFA9FC5C wds:Q65346013-9FE1C33D-853C-4EEF-BA8C-CCF8BFDCF99C wds:Q64626005-6A603301-77DC-4E21-B33B-E1F495C9D9F3 wds:Q65474672-94D1729C-8A78-47BE-9A81-5AC6478A4ED0 wds:Q63321817-C1138746-6F03-4378-8E9F-8ADE46FCC7F8 wds:Q62110271-DDAA79DE-8FA8-480B-AC86-37A9C906FB0E wds:Q64634724-7365BC32-7419-4F85-8C59-9EB58DF9A2FD wds:Q64351339-253CE0EA-3B5C-42BF-B190-803F7901A54D wds:Q64677677-1AEB2584-FD29-49AF-9710-4009AFBF07BF wds:Q65383632-8259DA8E-FAA1-4E3D-8ED0-36C6B5C6F276 wds:Q62040757-ECB7D90E-FFA9-45DD-BA25-AB5DAA32EBAD wds:Q64395998-E082D5E3-F4FF-4565-8F8C-C50B526F7B0B wds:Q65372304-0CE632BF-6B20-4511-9AAC-267D9BCF6CC8 wds:Q65355286-4B97B3A9-99BA-4180-885B-D575D159D3B8 wds:Q63341040-4EBB8BB8-C8C5-4760-82DA-DE88B33CE890 wds:Q62812014-EFE300EC-AC2F-4AF3-8EAE-510CBB725203 wds:Q65543128-9A2C9A3F-7E0E-4372-8746-D667C407FF9F wds:Q64600298-F4CAB89B-E65C-4639-99ED-0F055CCB6AF9 wds:Q63597162-36AE9D6F-1E56-41D2-89B4-C97C34DD4AE0 wds:Q64648610-0B898F84-9BA4-4745-92E1-F0C8CD5F1B07 wds:Q64725833-578C5962-A41D-4201-A5D6-33C51AD9EA28 wds:Q61937061-15828DE8-6E02-471B-A05A-DFFC1F6B0028 wds:Q64661887-D2DF7B13-C9CC-4461-936E-CD91B1275BED wds:Q65543130-91B4F393-9468-41FD-BF31-58BD9A420EFD wds:Q99956149-EE624774-47DB-44C6-8A50-F07F05ACE976

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software